Recruiting Cystic Fibrosis Studies in Miami
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
This study is a randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of ensifentrine inhalation suspension (3 mg) delivered twice daily via standard jet nebuli...
4D-710 in Adult Patients With Cystic Fibrosis
This is a Phase 1/2 multicenter, open-label, single dose trial of 4D-710 investigational gene therapy in adults with cystic fibrosis....
About Cystic Fibrosis Clinical Trials in Miami
Cystic fibrosis is a genetic disorder that causes thick, sticky mucus to build up in the lungs, digestive tract, and other organs. It is caused by mutations in the CFTR gene. CFTR modulator therapies have dramatically improved outcomes, along with airway clearance techniques and nutritional support.
There are currently 2 cystic fibrosis clinical trials recruiting participants in Miami, FL. These studies are seeking a combined 220 participants. Research is being sponsored by Verona Pharma plc, 4D Molecular Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Cystic Fibrosis Clinical Trials in Miami — FAQ
Are there cystic fibrosis clinical trials in Miami?
Yes, there are 2 cystic fibrosis clinical trials currently recruiting in Miami, FL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Miami?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you about next steps.
Are clinical trials in Miami free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami studies also compensate for your time and travel.
What cystic fibrosis treatments are being tested?
The 2 active trials in Miami are testing new therapies including novel drugs, biologics, and treatment approaches for cystic fibrosis.
Data updated March 2, 2026 from ClinicalTrials.gov